Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
JCI Insight
|
May 5, 2022
Activated CLL cells regulate IL-17F-producing Th17 cells in miR155-dependent and outcome-specific manners
Byeongho Jung, Gerardo Ferrer, Pui Yan Chiu, et al.
Cancers
|
October 14, 2023
Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli
Andrea N Mazzarello, Mark Fitch, Martina Cardillo, et al.
Blood
|
September 25, 2003
Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations
Rajendra N Damle, Franak M Batliwalla, Fabio Ghiotto, et al.
Blood
|
May 16, 2002
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes
Rajendra N Damle, Fabio Ghiotto, Angelo Valetto, et al.
JCI Insight
|
May 10, 2016
Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient process
Piers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Blood
|
August 20, 2009
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells
Till Seiler, Manuela Woelfle, Sophia Yancopoulos, et al.
The Journal of Clinical Investigation
|
February 16, 2005
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells
Bradley T Messmer, Davorka Messmer, Steven L Allen, et al.
Molecular Medicine (Cambridge, Mass.)
|
July 18, 2008
Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18)
Brian A McCarthy, Erin Boyle, Xue Ping Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2004
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621
Jonathan E Kolitz, Stephen L George, Richard K Dodge, et al.
Leukemia
|
January 28, 2021
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target
Florencia Palacios, Xiao-Jie Yan, Gerardo Ferrer, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
JCI Insight
|
May 5, 2022
Activated CLL cells regulate IL-17F-producing Th17 cells in miR155-dependent and outcome-specific manners
Byeongho Jung, Gerardo Ferrer, Pui Yan Chiu, et al.
Cancers
|
October 14, 2023
Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli
Andrea N Mazzarello, Mark Fitch, Martina Cardillo, et al.
Blood
|
September 25, 2003
Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations
Rajendra N Damle, Franak M Batliwalla, Fabio Ghiotto, et al.
Blood
|
May 16, 2002
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes
Rajendra N Damle, Fabio Ghiotto, Angelo Valetto, et al.
JCI Insight
|
May 10, 2016
Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient process
Piers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Blood
|
August 20, 2009
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells
Till Seiler, Manuela Woelfle, Sophia Yancopoulos, et al.
The Journal of Clinical Investigation
|
February 16, 2005
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells
Bradley T Messmer, Davorka Messmer, Steven L Allen, et al.
Molecular Medicine (Cambridge, Mass.)
|
July 18, 2008
Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18)
Brian A McCarthy, Erin Boyle, Xue Ping Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2004
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621
Jonathan E Kolitz, Stephen L George, Richard K Dodge, et al.
Leukemia
|
January 28, 2021
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target
Florencia Palacios, Xiao-Jie Yan, Gerardo Ferrer, et al.
Page
of 9